Maravai LifeSciences Holdings, Inc. MRVI Interest Expense
Interest Expense at other companies
Other financials
Where this comes from
Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.
The official record: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Maravai LifeSciences Holdings, Inc.'s interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Maravai LifeSciences Holdings, Inc.'s interest expense?
- Maravai LifeSciences Holdings, Inc. (MRVI) reported interest expense of $5.75M in Q1 2026.
- How has Maravai LifeSciences Holdings, Inc.'s interest expense changed year-over-year?
- Maravai LifeSciences Holdings, Inc.'s interest expense decreased by 15.2% year-over-year, from $6.78M to $5.75M.
- What is the long-term trend for Maravai LifeSciences Holdings, Inc.'s interest expense?
- Over 4 years (2021 to 2025), Maravai LifeSciences Holdings, Inc.'s interest expense has grown at a -2.8% compound annual growth rate (CAGR), from $30.26M to $26.99M.
- What does interest expense mean?
- Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.